A detailed history of Great West Life Assurance CO transactions in Xencor Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 75,245 shares of XNCR stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,245
Previous 80,876 6.96%
Holding current value
$1.87 Million
Previous $1.53 Million 1.05%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.7 - $21.65 $88,406 - $121,911
-5,631 Reduced 6.96%
75,245 $1.51 Million
Q2 2024

Aug 12, 2024

BUY
$18.21 - $24.5 $44,632 - $60,049
2,451 Added 3.13%
80,876 $1.53 Million
Q1 2024

May 13, 2024

BUY
$18.65 - $26.52 $59,866 - $85,129
3,210 Added 4.27%
78,425 $1.73 Million
Q4 2023

Feb 13, 2024

SELL
$16.53 - $21.42 $33,671 - $43,632
-2,037 Reduced 2.64%
75,215 $1.59 Million
Q3 2023

Nov 14, 2023

BUY
$20.08 - $25.39 $72,408 - $91,556
3,606 Added 4.9%
77,252 $1.56 Million
Q2 2023

Aug 10, 2023

SELL
$24.77 - $29.9 $55,038 - $66,437
-2,222 Reduced 2.93%
73,646 $1.84 Million
Q1 2023

May 12, 2023

SELL
$25.95 - $36.95 $106,680 - $151,901
-4,111 Reduced 5.14%
75,868 $2.11 Million
Q4 2022

Feb 10, 2023

BUY
$24.79 - $30.86 $85,723 - $106,713
3,458 Added 4.52%
79,979 $2.08 Million
Q3 2022

Nov 01, 2022

BUY
$24.62 - $32.44 $1.88 Million - $2.48 Million
76,521 New
76,521 $1.99 Million
Q2 2022

Aug 09, 2022

BUY
$19.74 - $29.01 $160,881 - $236,431
8,150 Added 16.15%
58,604 $1.61 Million
Q1 2022

May 12, 2022

BUY
$26.68 - $41.63 $10,405 - $16,235
390 Added 0.78%
50,454 $1.38 Million
Q4 2021

Feb 14, 2022

BUY
$33.67 - $43.44 $1,178 - $1,520
35 Added 0.07%
50,064 $2 Million
Q3 2021

Nov 15, 2021

BUY
$30.65 - $35.68 $37,576 - $43,743
1,226 Added 2.51%
50,029 $1.65 Million
Q2 2021

Aug 11, 2021

SELL
$34.33 - $44.68 $22,108 - $28,773
-644 Reduced 1.3%
48,803 $1.68 Million
Q1 2021

May 17, 2021

SELL
$40.81 - $53.88 $260,326 - $343,700
-6,379 Reduced 11.43%
49,447 $2.13 Million
Q4 2020

Feb 16, 2021

SELL
$36.63 - $47.63 $265,457 - $345,174
-7,247 Reduced 11.49%
55,826 $2.44 Million
Q3 2020

Nov 17, 2020

BUY
$30.09 - $43.02 $1.47 Million - $2.1 Million
48,772 Added 341.04%
63,073 $2.45 Million
Q3 2020

Nov 13, 2020

SELL
$30.09 - $43.02 $1.39 Million - $1.99 Million
-46,188 Reduced 76.36%
14,301 $554,000
Q2 2020

Aug 17, 2020

SELL
$27.76 - $33.42 $127,473 - $153,464
-4,592 Reduced 7.06%
60,489 $1.96 Million
Q1 2020

May 14, 2020

BUY
$20.69 - $37.79 $84,394 - $154,145
4,079 Added 6.69%
65,081 $1.94 Million
Q4 2019

Feb 11, 2020

BUY
$32.75 - $41.43 $2 Million - $2.53 Million
61,002 New
61,002 $2.1 Million
Q3 2019

Oct 25, 2019

SELL
$33.73 - $46.27 $220,121 - $301,958
-6,526 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$19.61 - $23.35 $127,974 - $152,382
6,526
6,526 $150,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.48B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.